Surrozen, Inc. has made headlines with its recent Schedule 13D/A filing, which updates the ownership structure of the company. This filing, submitted on October 22, 2026, reveals that the company has experienced significant changes in its share ownership due to recent private placements. The implications of this update are noteworthy for both Surrozen and the broader biological products industry.
Background
Surrozen, Inc., incorporated in Delaware, operates within the biological products sector, specifically focusing on products that do not include diagnostic substances. The company is publicly traded on the Nasdaq under the ticker symbol SRZN. Surrozen's recent filings include a variety of forms, with the most recent being a Schedule 13D/A and several Form 4 submissions on the same day, indicating active management of its securities.
What the Filing Says
The Schedule 13D/A filing serves as an amendment to a previous filing, originally submitted on August 23, 2021. This latest amendment updates the aggregate percentage of common stock owned by the reporting persons, primarily due to dilution from the company's sales of additional shares. The filing states, "This Amendment No. 7 is being filed to update the aggregate percentage of the Common Stock owned by the Reporting Persons due to dilution caused by the Issuer's sales of additional shares of Common Stock from time to time since the date of the Original 13D."
Impact
This update may affect various stakeholders, including existing shareholders and potential investors. The dilution of shares can impact the value of existing holdings, while new investors may see opportunities in the updated capital structure. Additionally, Surrozen's competitors in the biological products industry may need to reassess their strategies in light of these developments.
What's Next
The filing does not specify what happens next for Surrozen, but the company continues to engage in capital activities, as indicated by the recent private placements. These developments suggest that Surrozen is actively seeking to strengthen its financial position and expand its market presence.